Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy
Launched by THE CATHOLIC UNIVERSITY OF KOREA · Feb 22, 2008
Trial Information
Current as of May 06, 2025
Withdrawn
Keywords
ClinConnect Summary
Patients who have undergone gastrectomy for gastric cancer might be developed various symptoms by gastric stasis and bile reflux, it so called "post-gastrectomy syndrome", because of the diminishment of stomach capacity, the decrease of expulsive ability and the change of food passage. Until now, that had been accepted as the inevitable results after gastric resection. However, the survival rate has recently been increased owing to the increased proportion of early gastric cancer. And thus, to improve the quality of life of patients, many researchers have been actually studying for the reco...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patients who underwent distal gastrectomy for adenocarcinoma of stomach with following criteria:
- • 1. have cancer located in middle or distal portions
- • 2. preoperative staged as cT1N0M0 or cT2N0M0 by computed tomography and gastrofiberscope (Endoscopic ultrasound, optionally)
- • 3. have The American Society of Anaesthesiologists (ASA) score of three and less
- Exclusion Criteria:
- * Patients following criteria:
- • 1. have simultaneously other cancer
- • 2. underwent cancer therapy (radiologic or immunologic or chemotherapeutic method) at past time
- • 3. have systemic inflammatory disease
- • 4. have upper gastrointestinal surgery
- • 5. have the gastric cancer with obstruction
- • 6. get pregnancy
- • 7. are treating diabetics with Insulin
- • 8. are participating or participated within 1 month in other clinical trials
- • 9. have BMI less than 25
- • 10. are expected to perform laparoscopy assisted gastrectomy
About The Catholic University Of Korea
The Catholic University of Korea is a prestigious academic institution dedicated to advancing medical research and healthcare innovation. With a commitment to ethical standards and clinical excellence, the university actively sponsors clinical trials aimed at improving patient outcomes and enhancing medical knowledge. Its multidisciplinary approach fosters collaboration among experts in various fields, ensuring rigorous study design and comprehensive analysis. The Catholic University of Korea is dedicated to contributing significantly to the global medical community through its research initiatives and commitment to the highest standards of scientific integrity.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bucheon, , Korea, Republic Of
In Cheon, , Korea, Republic Of
Seoul, , Korea, Republic Of
Seoul, , Korea, Republic Of
Suwon, , Korea, Republic Of
Patients applied
Trial Officials
Wook Kim, MD, PhD
Principal Investigator
Department of Surgery, Holy Family Hospital, The Catholic University of Korea
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials